We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Zika Vaccine Shows Protective Efficacy in Monkeys

News   Dec 06, 2018 | Original story from the University of Hawai'i at Manoa

 
Zika Vaccine Candidate Effective in Preclinical Trials

Zika virus results in neurological complications in babies born from infected mothers. The immunogenicity and protective efficacy of a recombinant subunit vaccine candidate has been demonstrated in mice, and in long-tailed macaques (Macaca fascicularis, also known as the crab-eating macaque). Image credit: Mr. Theklan.

 
 
 

RELATED ARTICLES

Metabolic Dysfunction Could Be a Potential Therapy for Alzheimer’s Disease

News

A team of researchers led by Yale-NUS College has found evidence that metabolic dysfunction is a primary cause of Alzheimer's disease.

READ MORE

Combatting Superbugs With Nanocapsules

News

Scientists have discovered an antibiotic-free approach that could help prevent and treat one of the most widespread bacterial pathogens, using nanocapsules.

READ MORE

Bioactive Agents Improve Synthetic Bone Substitutes

News

Synthetic bone substitutes are promising materials for bone defect repair, but their efficacy can be substantially improved by bioactive agents such as growth factors. In a new study, researchers have modified beta-tricalcium phosphate (β-TCP) with increasing quantities of bone morphogenetic protein 2 (BMP-2) derived from E. coli and shown improved bone healing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE